Research
Cellular
Long-term safety monitoring of new obesity drugs is necessary due to potential serious adverse events.
Practitioners should prioritize safety monitoring for new obesity treatments.
StrongSupportsmedium confidence
These drugs should be evaluated over a wide array of end-points; in particular, long-term safety monitoring is necessary as serious adverse events may appear.
Why this rating
The claim is based on expert opinion regarding drug safety.
Source
Emerging drugs for the treatment of obesity
Christoffer Martinussen et al. · Expert Opinion on Emerging Drugs · 2016
DOI 10.1080/14728214.2017.1269744
reviewCited 27×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →